Obesity: A Comprehensive Guide to Understanding and Managing This Metabolic Condition
What is Obesity?
Obesity is a complex metabolic condition characterized by excessive accumulation of body fat that presents a risk to health. It occurs when energy intake from food and drink consistently exceeds energy expenditure through metabolism and physical activity over an extended period. Obesity affects people of all ages, genders, and socioeconomic backgrounds worldwide, with prevalence rates continuing to rise globally. According to the World Health Organization, obesity has nearly tripled worldwide since 1975, making it one of the most significant public health challenges of the 21st century.
Key statistics
| Global prevalence (adults) | 13% (650+ million people) |
| Childhood obesity prevalence | 6% globally (39 million children under 5) |
| Annual deaths attributed to obesity | 2.8 million worldwide |
| Economic burden | $2 trillion annually in healthcare costs |
Symptoms
Primary indicators: Excess body weight, increased waist circumference, elevated body mass index (BMI), difficulty with physical activities, shortness of breath during routine activities.
Early and common symptoms: Individuals with obesity may experience fatigue and reduced energy levels, particularly during physical exertion. Joint pain, especially in weight-bearing joints like knees and hips, is common due to increased mechanical stress. Sleep disturbances, including sleep apnea, frequently develop as excess weight affects breathing patterns during rest.
Progressive symptoms: As obesity advances, people may notice increased sweating, heat intolerance, and skin problems including rashes in skin folds. Gastroesophageal reflux disease (GERD) often develops due to increased abdominal pressure.
Serious complications: Advanced obesity can lead to severe breathing difficulties, mobility limitations, and significant impacts on cardiovascular function. Depression and anxiety may develop due to both biological factors and social stigma associated with weight.
Causes and risk factors
Obesity results from a complex interplay of genetic, environmental, behavioral, and physiological factors. Genetic factors account for approximately 40-70% of obesity risk, with over 100 genetic variants identified that influence body weight regulation, metabolism, and fat distribution.
Environmental factors include readily available high-calorie processed foods, large portion sizes, and sedentary lifestyles promoted by modern technology and urban design. Socioeconomic factors play a significant role, as limited access to healthy foods and safe exercise environments disproportionately affects lower-income communities.
Medical risk factors include certain medications (antidepressants, antipsychotics, corticosteroids), hormonal disorders (hypothyroidism, Cushing’s syndrome, polycystic ovary syndrome), and medical conditions that limit physical activity. Psychological factors such as stress, trauma, and eating disorders can contribute to weight gain through altered eating behaviors and metabolic changes.
Age and life stage factors include pregnancy, menopause, and natural metabolic changes that occur with aging. Sleep deprivation and shift work can disrupt hormonal regulation of hunger and satiety.
Prevention
Evidence-based prevention strategies focus on maintaining energy balance through healthy eating patterns and regular physical activity. The most effective approach involves establishing sustainable lifestyle habits early in life and maintaining them throughout adulthood.
Dietary prevention includes consuming a balanced diet rich in fruits, vegetables, whole grains, and lean proteins while limiting processed foods, sugary beverages, and excessive portion sizes. The Mediterranean diet pattern has strong evidence for weight maintenance and overall health benefits.
Physical activity recommendations include at least 150 minutes of moderate-intensity aerobic activity weekly for adults, plus muscle-strengthening activities on two or more days per week. For children, at least 60 minutes of daily physical activity is recommended.
Environmental modifications involve creating supportive environments that promote healthy choices, such as workplace wellness programs, community gardens, safe walking paths, and policies that improve food environments in schools and communities.
Early intervention through regular monitoring of weight and BMI, particularly during high-risk periods such as childhood, adolescence, early adulthood, and major life transitions, can prevent progression to obesity.
Complications
Untreated obesity significantly increases the risk of numerous serious health conditions. Cardiovascular complications include hypertension, coronary artery disease, stroke, and heart failure. The risk of type 2 diabetes increases dramatically, with obesity being the leading modifiable risk factor for this condition.
Metabolic complications include metabolic syndrome, dyslipidemia, and non-alcoholic fatty liver disease, which can progress to cirrhosis. Respiratory complications encompass sleep apnea, asthma, and obesity hypoventilation syndrome.
Musculoskeletal problems include osteoarthritis, particularly in weight-bearing joints, back pain, and increased risk of fractures. Cancer risk is elevated for multiple types, including breast, colorectal, endometrial, kidney, and liver cancers.
Reproductive complications affect both men and women, including reduced fertility, pregnancy complications, and hormonal imbalances. Mental health impacts include increased rates of depression, anxiety, and reduced quality of life due to social stigma and functional limitations.
Diagnosis
Obesity diagnosis primarily relies on anthropometric measurements and clinical assessment. Body Mass Index (BMI) is the most widely used screening tool, calculated as weight in kilograms divided by height in meters squared. BMI categories include: normal weight (18.5-24.9), overweight (25.0-29.9), Class I obesity (30.0-34.9), Class II obesity (35.0-39.9), and Class III obesity (≥40.0).
Additional diagnostic measurements include waist circumference, which provides information about abdominal fat distribution and metabolic risk. Waist-to-hip ratio and body composition analysis using methods like DEXA scans or bioelectrical impedance may provide additional insights.
Laboratory tests assess obesity-related complications and metabolic status, including fasting glucose and hemoglobin A1C, lipid profile, liver function tests, and thyroid function tests. Sleep studies may be recommended to evaluate for sleep apnea.
Clinical evaluation includes comprehensive medical history to identify underlying causes, medication review, assessment of eating behaviors, physical activity levels, and evaluation for obesity-related complications.
Treatment
Obesity treatment employs a multi-modal approach tailored to individual needs, severity, and comorbidities. The foundation involves lifestyle interventions combining dietary modification, increased physical activity, and behavioral counseling.
Pharmacological treatments may be considered for individuals with BMI ≥30 or BMI ≥27 with obesity-related comorbidities. FDA-approved medications include orlistat, which blocks fat absorption; liraglutide and semaglutide, GLP-1 receptor agonists that reduce appetite; naltrexone-bupropion, which affects brain reward pathways; and phentermine-topiramate, which suppresses appetite.
Bariatric surgery is considered for individuals with BMI ≥40 or BMI ≥35 with significant comorbidities when non-surgical treatments have been unsuccessful. Procedures include gastric bypass, sleeve gastrectomy, and adjustable gastric banding, each with different mechanisms and outcomes.
Behavioral interventions include cognitive-behavioral therapy, stress management, sleep hygiene improvement, and addressing emotional eating patterns. Structured weight management programs with regular monitoring and support show improved long-term outcomes.
Prognosis
The prognosis for obesity varies significantly based on the degree of weight loss achieved, duration of obesity, presence of complications, and individual factors. With appropriate treatment, many people can achieve clinically meaningful weight loss (5-10% of initial body weight) that substantially improves health outcomes and quality of life.
Long-term outcomes depend heavily on sustained lifestyle changes and ongoing support. Studies show that individuals who maintain weight loss for two years have a much higher likelihood of long-term success. Bariatric surgery typically results in 20-30% total body weight loss with significant improvement in obesity-related conditions.
Mortality considerations: Severe obesity can reduce life expectancy by 6-7 years on average, primarily due to cardiovascular disease, diabetes complications, and cancer. However, even modest weight loss significantly reduces mortality risk and improves overall health outcomes.
Quality of life
Living successfully with obesity involves developing sustainable lifestyle patterns that support both physical and mental well-being. Establishing regular meal planning with appropriate portion sizes, incorporating enjoyable physical activities, and building strong support networks are fundamental elements.
Daily management strategies include keeping food diaries, planning meals in advance, staying hydrated, and finding non-food ways to manage stress and emotions. Creating an environment that supports healthy choices, such as keeping nutritious foods readily available and removing tempting processed foods, facilitates success.
Exercise adaptation should begin gradually with low-impact activities like walking, swimming, or cycling, progressively increasing intensity and duration as fitness improves. Strength training helps preserve muscle mass during weight loss and improves metabolic health.
Mental health support is crucial, as obesity often involves complex emotional relationships with food. Professional counseling, support groups, and stress management techniques help address underlying psychological factors and develop healthy coping strategies.
Social considerations include building supportive relationships, addressing weight stigma, and finding communities of individuals with similar health goals. Workplace accommodations may be necessary for individuals with mobility limitations or obesity-related health conditions.
Pregnancy and fertility
Obesity significantly impacts both male and female fertility and pregnancy outcomes. In women, obesity can cause irregular menstrual cycles, ovulation disorders, and reduced success rates with fertility treatments. The risk of pregnancy complications increases substantially, including gestational diabetes, hypertension, preeclampsia, and birth defects.
Preconception counseling is essential for individuals with obesity who are planning pregnancy. Achieving weight loss before conception improves fertility outcomes and reduces pregnancy complications. However, weight loss attempts should be completed before pregnancy, as restrictive dieting during pregnancy can harm fetal development.
Medication considerations during pregnancy require careful evaluation, as most weight-loss medications are contraindicated during pregnancy and breastfeeding. Metformin may be used in some cases for diabetes management during pregnancy.
Postpartum management focuses on gradual, healthy weight loss while supporting breastfeeding when applicable. Breastfeeding can aid in postpartum weight loss while providing optimal nutrition for the infant.
Children
Childhood obesity presents unique challenges and opportunities for intervention. Early identification and family-based interventions are most effective, as dietary and activity patterns established in childhood often persist into adulthood.
Pediatric assessment uses age- and sex-specific BMI percentiles rather than adult BMI categories. Children with BMI ≥85th percentile are considered overweight, while those ≥95th percentile are classified as having obesity.
Family-centered approach is essential, as children’s eating and activity behaviors are largely influenced by family environment. Successful interventions involve the entire family in making healthy lifestyle changes rather than focusing solely on the child with obesity.
School accommodations may be necessary for children with obesity-related health issues or mobility limitations. Physical education modifications, ergonomic seating, and anti-bullying policies help create supportive educational environments.
Transition planning to adult care involves gradually transferring responsibility for health management to the adolescent while maintaining family support and professional guidance.
When to see a doctor
Routine medical care should be sought if BMI indicates overweight or obesity, or if there are concerns about weight gain patterns. Regular monitoring helps identify obesity-related complications early when they are most treatable.
Urgent medical attention is needed for symptoms of severe complications, including chest pain, severe shortness of breath, signs of sleep apnea (loud snoring with breathing pauses), symptoms of diabetes (excessive thirst, urination, fatigue), or severe joint pain that limits daily activities.
Immediate care is required for any symptoms suggesting heart attack, stroke, or other cardiovascular emergencies, which occur at higher rates in individuals with obesity. Mental health crises, including severe depression or suicidal thoughts, require prompt professional intervention.
Specialized referral may be appropriate for individuals who have not achieved weight loss goals with standard approaches, those considering bariatric surgery, or people with complex medical conditions requiring specialized management.
Regional context
Obesity prevalence in the Caucasus region shows significant variation, with rates generally lower than Western countries but increasing rapidly due to nutrition transition and lifestyle changes. Georgia reports adult obesity rates of approximately 21%, while Armenia and Azerbaijan show similar trends with urbanization and dietary pattern changes.
Regional challenges include traditional high-calorie foods, limited access to modern healthcare in rural areas, and economic factors affecting food choices. Cultural attitudes toward body weight and traditional gender roles may influence treatment-seeking behavior and family involvement in lifestyle interventions.
GMJ welcomes contributions from regional researchers to build the evidence base for obesity prevention and treatment strategies specific to Caucasus populations.
Research and clinical trials
Current obesity research focuses on developing more effective medications, understanding genetic factors, and improving long-term weight maintenance strategies. Promising areas include GLP-1 receptor agonist combinations, novel surgical techniques, and personalized medicine approaches based on genetic and metabolic profiling.
Emerging therapies under investigation include dual and triple hormone receptor agonists, gut microbiome modulation, and brown adipose tissue activation strategies. Gene therapy and precision medicine approaches show potential for treating rare genetic forms of obesity.
Clinical trial participation can be found through ClinicalTrials.gov, which lists current studies investigating new treatments, behavioral interventions, and prevention strategies. Participation in clinical trials may provide access to cutting-edge treatments while contributing to scientific advancement.
Frequently asked questions
Is obesity really a disease or just a lifestyle choice?
Obesity is recognized as a complex medical condition by major health organizations worldwide. While lifestyle factors play a role, genetic, metabolic, and environmental factors significantly influence body weight regulation, making it much more than a simple matter of personal choice.
Can you be healthy at any size?
While metabolic health can vary among individuals with obesity, excess weight generally increases health risks. Some people with obesity may have normal metabolic markers temporarily, but long-term health risks typically increase with higher BMI levels.
Why is weight loss so difficult to maintain?
The body has powerful biological mechanisms that defend against weight loss, including hormonal changes that increase hunger and decrease metabolism. These evolutionary adaptations made sense for survival but work against weight loss in modern environments with abundant food.
Are weight-loss medications safe for long-term use?
Currently approved weight-loss medications have undergone extensive safety testing and are considered safe for long-term use under medical supervision. Regular monitoring helps identify any potential side effects early, and benefits typically outweigh risks for appropriate candidates.
How much weight loss is needed to see health benefits?
Even modest weight loss of 5-10% of initial body weight can produce significant health improvements, including better blood sugar control, reduced blood pressure, improved sleep, and decreased joint pain. Greater weight loss typically provides additional benefits.
Support and resources
International organizations:
– World Obesity Federation (www.worldobesity.org) – Global advocacy and research organization
– Obesity Action Coalition (www.obesityaction.org) – Patient advocacy and education
– International Association for the Study of Obesity (www.iaso.org) – Professional organization for obesity research
Professional societies:
– American Society for Metabolic and Bariatric Surgery (asmbs.org) – Surgical treatment resources
– The Obesity Society (obesity.org) – Research and clinical guidelines
– World Health Organization (who.int) – Global health policy and
Cite this page
GMJ News Desk. “Obesity.” GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/condition/obesity/
Licensed under CC BY 4.0. Free to share with attribution to GMJ News.Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.
Was this article helpful?
- GLP-1 Drugs Linked to Lower Violent Behaviour in Rutgers Study · Jul 11, 2026
- Native Hawaiian Adults Face Mobility Decline Years Earlier Than Peers · Jul 10, 2026
- Beyond GLP-1 drugs: Why obesity care requires more than medication · Jul 9, 2026
- Semaglutide Linked to Fewer Bone Fractures Despite Greater Weight Loss in Type 2 Diabetes · Jul 9, 2026
- Peer Support Group Addresses Rising Loneliness Crisis Among Young Adults Following Suicide Death · Jul 9, 2026


